Minor
COMPASS 2-HS · BFB759 in Moderate to Severe Hidradenitis Suppurativa
Trial sites expanded: 58 → 64 locations
And 1 more change in the last 30 days
Bluefin Biomedicine, Inc.Phase 2/3 NCT07287644 Registry history of NCT07287644 on ClinicalTrials.gov (opens the registry)